A new cholera outbreak in Sudan has killed over 170 people in a week, officials say
On Saturday, Sudan's Health Minister Haitham Ibrahim said the increase in cholera cases just in the Khartoum region has been estimated to average 600 to 700 per week over the past four weeks.
Bekker said MSF's treatment centers in Omdurman are overwhelmed and that the 'scenes are disturbing.'
Advertisement
'Many patients are arriving too late to be saved,' she said. 'We don't know the true scale of the outbreak, and our teams can only see a fraction of the full picture.'
She called for a united response, including water, sanitation and hygiene programs and more treatment facilities.
In March, MSF said that 92 people had died of cholera in Sudan's White Nile State, where 2,700 people had contracted the disease since late February.
The World Health Organization said that the water-borne disease is a fast-developing and highly contagious infection that causes diarrhea and leads to severe dehydration and possible death within hours when not treated. The disease is transmitted through the ingestion of contaminated food or water.
Advertisement
The outbreak is the latest crisis for Sudan, which was plunged into a war more than two years ago, when tensions between the Sudanese army and its rival paramilitary Rapid Support Forces group, or RSF, exploded with street battles in Khartoum that quickly spread across the country.
Since then, at least 20,000 people have been reported killed, though the number is likely far higher, and more than 14 million have been displaced and forced from their homes.
Sudan has also been engulfed by what the United Nations says is the world's largest humanitarian crisis, and disease outbreaks, famine and atrocities have mounted as the African country entered its third year of war.
Last week, the Sudanese military said it had regained control of the Greater Khartoum area from the paramilitary forces.
Ibrahim, the health minister, attributed the cholera surge to the return of many Sudanese to the Khartoum region — people who had fled their homes to escape the fighting and are now coming back. Their returns have strained the city's dwindling water resources, he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
2 hours ago
What to know about COVID variant NB.1.8.1 causing 'razor blade throat'
A newer COVID-19 variant may be causing a severe sore throat in some people who contract the infection. The variant, known as NB.1.8.1, has been nicknamed by some as "razor blade throat" due to the painful symptom. Data from the open global genome sequencing database GISAID shows the new variant has been detected in several states, including New York, Illinois, Texas and California. Public health experts told ABC News there is no cause for serious concern yet because the virus does not appear to be more severe than previous variants and there are steps that can be taken to protect yourself. What is NB 1.8.1? NB.1.8.1 derives from the recombinant variant XVD.1.5.1, which is a descendant of the omicron variant. The first sample of NB.1.8.1 was collected on Jan. 22, according to the World Health Organization (WHO). It was first detected in China and other parts of Asia before spreading to Europe. It was designated as a "variant under monitoring" by the WHO, meaning it may require prioritized attention and monitoring but is not as serious as a "variant of interest" or a "variant of concern." As of the week ending June 7, NB.1.8.1 is the second most dominant variant in the U.S., accounting for an estimated 37% of cases, according to the Centers for Disease Control and Prevention (CDC). The virus appears to be more transmissible because there appear to be changes to the spike protein, which is what the virus uses to attach to and infect cells, said Dr. Peter Chin-Hong, a professor of medicine and infectious disease specialist at the University of California, San Francisco. It also seems to attach more easily to ACE2 receptors, which are proteins found on the surface of cells and how the virus that causes COVID enters cells, he told ABC News. NB.1.8.1 doesn't yet appear to be causing increases in cases or in hospitalizations with rates remaining "stable" so far, according to Chin-Hong. The variant has also been called "Nimbus," which appears to have been coined on X by T. Ryan Gregory, a Canadian professor of evolutionary biology. "Nimbus is a catchy, quick name, and it also includes an 'N' and a 'B' from the lineage, which is NB.1.8.1. So it's easier for people to be able to say these monikers for COVID, rather than remember the actual lineage," said Dr. Alok Potel, a pediatrician at Stanford Children's Health and an ABC News contributor. "But I think it's important also because it keeps people paying attention to new COVID variants that can be different in terms of infectivity and in terms of spread," he added. What are the symptoms? Experts said they are not sure if the painful sore throat is just a symptom that people are talking about or a distinctive symptom of this variant. It's also unclear if the "razor blade throat" is more common in those who are more up to date on vaccination compared to those who are not up to date. "I think it's certainly amongst the spectrum of symptoms that you can get, and we know that sore throat is reported by about 70% of patients now with COVID, so it's not unusual, and like with everything in medicine, there's always a spectrum," Chin-Hong said. There is currently no evidence that NB.1.8.1. causes more severe disease or is more likely to cause hospitalization, according to Dr. William Schaffner, a professor of preventive medicine at Vanderbilt University Medical Center in Nashville, "But of course, there are people in high-risk groups that are still at risk of being hospitalized should they become infected," he told ABC News. There are no other symptoms outlined that are specific to NB.1.8.1 by the CDC. Symptoms listed by the health agency still include sore throat, cough, fever, chills, shortness of breath, difficulty breathing, congestion, runny nose, loss of taste or smell, fatigue, muscle aches, body aches, headache, nausea, vomiting or diarrhea. How to protect yourself The experts recommend that high-risk Americans receive a vaccine twice a year as recommended by the CDC. The CDC also currently recommends most adults aged 18 and older receive an updated 2024-2025 vaccine and that parents of children between ages 6 months to 17 years discuss the benefits of vaccination with a health care provider. COVID-19 also tends to spike in the late summer and early fall, so people should consider opening windows to increase ventilation, wearing a mask in certain situations and avoiding crowded areas, Schaffner said. "Time to stream a movie, as I like to say, rather than going to the movies," he added. Patel said it's important to practice good hygiene such as proper hand-washing and covering your mouth when coughing or sneezing. He also recommended that people test if they are symptomatic and said over-the-counter rapid at-home tests work. "Getting infected with COVID and other infectious diseases is not necessarily life or death, but it can still be very debilitating." Patel said. "It can cause people to miss work, to spread the virus, to get people who are higher risk sick and there's still an untold amount of people who have long COVID." He added, "So, we don't want to look at COVID as just another common cold, because there's still so much we're learning about it, and there's still so many possibilities with this virus continuing to mutate, if we let it."
Boston Globe
4 hours ago
- Boston Globe
Trump travel restrictions bar residents needed at US hospitals
'If international medical graduates can't start their medical residencies on time on July 1, the ramifications are so far-reaching that it is really unconscionable,' said Kimberly Pierce Burke, executive director of the Alliance of Independent Academic Medical Centers. Senior residents leave hospitals in June and go on to start their careers, she noted. Hospitals rely on new residents to replenish their ranks. 'If they don't come on July 1, that leaves a hole in the patient care team,' Burke said. 'Who's going to pick up the slack?' Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up On May 27, the Trump administration suspended new interview appointments for foreign nationals applying for J-1 visas. The visas, for participants in cultural or educational exchange programs, are used by most medical residents arriving from overseas. Advertisement On Wednesday, the State Department lifted the pause on visa appointments, according to an official who spoke anonymously to discuss an internal policy change. It was not immediately clear how many, or how quickly, physicians could be granted their visas. The process now includes 'enhanced social media vetting,' intended to ferret out potential security risks, the official said. The administration also has banned or restricted travel to the United States from 19 countries. The restrictions may be extended to an additional 36 countries, including many African nations, if they do not comply with U.S. demands regarding overstayed visas and security concerns. Advertisement The bans and restrictions were motivated by a commitment 'to protecting our nation and its citizens by upholding the highest standard of national security and public safety through our visa process,' the State Department official said. Foreign doctors from countries covered by the bans and other restrictions could request a 'national interest exception,' according to the State Department. It was not immediately clear how that process would unfold. The American medical system relies heavily on physicians from other countries. One in five U.S. physicians was born and educated overseas, according to the Association of American Medical Colleges. New doctors from other countries account for 1 in 6 medical residents and specializing fellows at U.S. teaching hospitals. In 2024, the Educational Commission for Foreign Medical Graduates sponsored more than 15,500 doctors from more than 150 countries to fill residency or fellowship training spots at 770 hospitals. Related : Residents are new medical school graduates who complete their training by working for several years under the supervision of more experienced doctors, gaining experience and acquiring the skills needed for various specialties. They work up to 80 hours a week on average, earning relatively low salaries. Residents are the foot soldiers of hospitals, critical to their operations, said Dr. Douglas DeLong, a semiretired physician in upstate New York who has worked in academic training programs. 'If you're a patient in a hospital, the resident is the first doctor you see in the morning,' DeLong said. Many foreign medical residents stay and build their careers in the United States. Most go into primary care fields such as internal medicine, family medicine and pediatrics, areas of shortage that American medical graduates tend to avoid. Advertisement Many of the 6,653 noncitizen doctors accepted for residency positions in the United States this year had already secured visa appointments before May 27. Those from banned countries who are already in the country are able to remain. But an estimated 1,000 medical residents were not able to obtain visas allowing them to work in the United States. The vacancies will have disparate effects on hospitals, depending how heavily reliant they are on foreign medical talent. At Brookdale Hospital Medical Center in the Brooklyn borough of New York City, people queued up for emergency care Monday. The lobby thrummed with visitors clutching bouquets of roses, and patients nodded off on benches, waiting to be seen. Like many hospitals in underserved communities, Brookdale relies heavily on international medical graduates who are not U.S. citizens to staff the medical and pediatrics floors and outpatient clinics. 'It's a wait-and-watch situation,' Dr. Christos Paras, who oversees the residency program, said in an interview. 'We just don't know what the impact will be.' 'We have residents from literally all over the world,' he added. 'I am not exaggerating — every continent.' Brookdale's internal medicine residency program relies on foreign medical graduates to staff about 90% of its 55 positions. So far, two noncitizens have been blocked from entering the country, said Dr. Conrad Fischer, director of the program. 'If I am missing two or three people, I can go out and get the spots filled,' Fischer added. 'But next year, we're not talking about missing two or three — we're talking about missing thousands.' Advertisement If the travel restrictions are maintained, 'it would gut the program,' he said. Dr. Christos Paras, who oversees Brookdale's residency program, at the hospital on Monday. Paras said that Brookdale doesn't know "what the impact will be" on Trump's travel ban. NICOLE CRAINE/NYT Hospitals and clinics in rural areas of the country already struggle to recruit graduates of U.S. medical schools to their residency programs. They rely heavily on international graduates. New foreign doctors are not taking residency positions away from American medical school graduates. Just the opposite: This year, there were about 40,000 residency positions offered through the national match system, but only 28,000 graduates of U.S. medical schools. Foreign residents fill a crucial labor shortage. Hospitals are not allowed to overwork residents and may lose their accreditation as medical teaching institutions if they do. An insufficient number of residents could also cost them Medicare funds tied to graduate medical education. The noncitizen international medical graduates who make it to U.S. training programs are 'well-trained, well-qualified and motivated,' DeLong said. 'This is the new generation of physicians for Americans,' he added. 'These are the physicians who will take care of us as we age. They are the future of medicine.' This article originally appeared in .
Health Line
9 hours ago
- Health Line
New COVID Variant Nimbus May Cause Painful ‘Razor Blade Throat' Symptom
The Nimbus variant of COVID-19 is on the rise, as many have reported a painful symptom they're calling 'razor blade throat.' If you have a severe sore throat, it's important to get tested to rule out strep throat to avoid severe complications. COVID-19 precautions like masking and vaccination remain important. A newly identified COVID-19 variant called 'Nimbus' is rapidly spreading in the United States and making headlines with a common symptom that's turning heads in exam rooms. People contracting a COVID-19 infection are reporting an unusually intense sore throat, described as feeling like swallowing razor blades. Some think this symptom, dubbed 'razor blade throat,' may set this variant apart from earlier ones. However, experts aren't so sure. Sore throat has long been recognized as a COVID-19 symptom. Early data suggest Nimbus may not cause more severe illness overall, but reports of severe sore throats are raising questions about how this variant might differ from its predecessors. Here's what experts told Healthline about the Nimbus variant — and what you should know. Nimbus is more transmissible, but not as severe According to the World Health Organization (WHO), Nimbus, also known as NB.1.8.1, is a subvariant of the Omicron variant of the SARS-CoV-2 virus that causes COVID-19. Yale School of Medicine Assistant Professor Scott Roberts, MD, explained that Nimbus currently accounts for about one-third of COVID-19 cases in the United States. 'It is more transmissible than the current circulating variants because of several mutations in the spike protein that make it distinct from the others,' he told Healthline. 'But, it is still an omicron subvariant related to some variants that were circulating previously, so I suspect there will be an increase in cases, but not a wave to the degree we have had previously.' Kartik Cherabuddi, MD, FIDSA, Chief Hospital Epidemiology Officer at Tampa General Hospital, noted that while Nimbus is currently surging around the world, the public health risk is still low compared to other Omicron lineages. 'Early and limited laboratory data do not show a significant capability to evade the immune system or increased resistance to antiviral treatment,' he told Healthline. Cherabuddi added that no reported studies are currently available on the impact of Nimbus on clinical outcomes. However, '[r]outine surveillance, so far, does not reveal an increase in hospitalization or death,' he said. 'Razor blade throat' may not be a new COVID symptom Roberts said the symptoms of the Nimbus variant are the same as those of prior COVID-19 variants, including fever, cough, and sore throat. 'The 'razor blade throat' is anecdotal and there is no evidence to suggest that this variant leads to more severe sore throat than other variants,' he added. Roberts advised, however, if you do have a sore throat, it would be a good idea to test for COVID-19 to make sure it is not the cause. If your sore throat is severe, he also recommends checking in with your doctor to rule out strep throat. Other common symptoms of COVID-19 include loss of taste or smell and fatigue. Less frequently, individuals may experience: sore throat headaches body aches diarrhea skin rash discoloration of fingers or toes red, irritated eyes Symptoms of strep throat may include: sudden fever sore throat with white patches headache chills loss of appetite swollen lymph nodes problems with swallowing Experts say it's important to distinguish strep throat from COVID-19. Unlike COVID-19, which is caused by a virus, strep throat is a bacterial infection caused by group A Streptococcus. Strep throat often requires antibiotic treatment to prevent potentially serious complications. These may include peritonsillar abscesses (pus-filled infections behind the tonsils), rheumatic fever (which can damage the heart, joints, and skin), post-streptococcal glomerulonephritis (a type of kidney inflammation), and, in rare cases, streptococcal toxic shock syndrome or meningitis. How to protect yourself from the Nimbus variant The first thing to know about protecting yourself from the Nimbus variant is that nothing has really changed in this department. 'The same tools that worked before will still work: handwashing, avoiding people who are sick, good ventilation, getting vaccinated, and masking in high risk settings,' said Roberts. The CDC recommends the vaccine for most adults ages 18 and older to maintain protection against severe illness, hospitalization, and death. Older adults, high risk individuals, and those who've never been vaccinated are especially encouraged to get it. Parents should consult a healthcare professional for kids under 18. The CDC additionally notes that immunity from previous vaccines wanes over time, making updated vaccination important. COVID-19 vaccine recommendations may also change soon, making it more difficult for healthy adults, children, and pregnant people to get one. Cherabuddi added there are certain symptoms that would indicate you need to consult with a physician, such as: severe throat pain throat pain that lasts longer than a week weight loss food sticking in your throat new or worsened shortness of breath 'If any of these red flags occur, have it checked out,' he said.
